NCT05361668 2026-03-19Study to Evaluate the Safety, PK, and Dose Response of Paltusotine in Subjects With Carcinoid SyndromeCrinetics Pharmaceuticals Inc.Phase 2 Completed36 enrolled 19 charts
NCT06550739 2024-08-13Comprehensive Prognostic Model: The Study Introduces a Novel Prognostic Model That Incorporates a Wide Range of Clinical and Laboratory Variables, Providing a More Holistic Approach to Predicting Overall Survival in HCC PatientsChongqing University Cancer HospitalCompleted1,053 enrolled